Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01643603
Brief Title: Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies

First Submitted : May 30, 2012
First Submitted that Met QC Criteria : July 16, 2012
First Posted : July 18, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : January 2, 2019
Last Update Posted : January 4, 2019